An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections
- Conditions
- Bacterial Infections
- Registration Number
- NCT06211829
- Lead Sponsor
- Methodist Health System
- Brief Summary
In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR), and the recommendations were communicated to the primary team via secure messaging or telephone
- Detailed Description
Evaluation of the Staphylococcus aureus bloodstream infection(SAB)bundle recommendations will allow for determination of whether this intervention is impactful and warrants the resources currently devoted to it.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 208
- 18 years of age SAB during hospital admission
- Patients with a history of a prior SAB during the study period (only first occurrence included)
- Blood culture collected within 48hours of patient expiring or transitioning to hospice
- Patients discharged or left before culture results were available
- Patients transferred from an outside hospital
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of Staphylococcus Aureus blood stream infections (SAB) 12 weeks Number of SAB occurring
- Secondary Outcome Measures
Name Time Method Number of In-hospital mortality 12 weeks Number of In-hospital mortality
number of times of bacteremia 12 weeks time of bacteremia
number of infection 12 weeks Number of times the infection is occurring
number of days of stay 12 weeks duration of hospital stay
number of times of readmission 12 weeks Number time of readmission
Trial Locations
- Locations (1)
Methodist Dallas Medical Center
🇺🇸Dallas, Texas, United States